Sort
82,697 grants matching “vaccine development”
Manufacturing of Drug Product, Dual Aβ/tau Vaccine for Clinical Trials
$2,270,000Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2023 · AG
Malaria Drug Resistance and Disease Virulence
$2,269,751Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Role of B Lymphocytes In HIV Infection And Pathogenesis
$2,269,182Susan Moir · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Structure-function analysis of infection- and vaccine-induced B-cell repertoires
$2,268,881Stephen C Harrison · Boston Children'S Hospital · P01 · FY2014 · AI
Laboratory And Preclinical Studies Of Dengue Viruses
$2,268,725Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
ETIB Clinical Research Core
$2,268,710Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2013 · CA
A vaccine design to induce protective B and T cell immunity against hepatitis C virus
$2,268,699Steven Foung · Stanford University · U19 · FY2025 · AI
Adoptive Cell Transfer Immunotherapy of Cancer
$2,268,631Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY
$2,268,617Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission
$2,268,135Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Programming HIV Immunity for Broadly Neutralizing Antibodies by Vaccination
$2,268,093Nancy Logan Haigwood · Oregon Health & Science University · P01 · FY2013 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$2,267,196Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2019 · AI
(HVTN) HIV VACCINE TRIAL UNITS
$2,267,098Johns Hopkins University · U01 · FY2000 · AI
SPORE in Lymphoma
$2,266,618Helen E Heslop · Baylor College Of Medicine · P50 · FY2009 · CA
SPORE in Lymphoma
$2,266,618Helen E Heslop · Baylor College Of Medicine · P50 · FY2010 · CA
SPORE in Lymphoma
$2,266,618Helen E Heslop · Baylor College Of Medicine · P50 · FY2008 · CA
SPORE in Lymphoma
$2,266,618Helen E Heslop · Baylor College Of Medicine · P50 · FY2007 · CA
Center on Emerging and Zoonotic Infectious Diseases
$2,266,526Juergen A Richt · Kansas State University · P20 · FY2021 · GM
Optical Technologies and Molecular Imaging for Cervical Neoplasia
$2,266,232Michele Follen · Brookdale Univ Hospital & Medical Center · P01 · FY2014 · CA
Biodefense/Emerging Infection Vaccine Studies
$2,265,989Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY
$2,265,914Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2017 · AI
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)
$2,265,730Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2022 · AI
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)
$2,265,730Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2023 · AI
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)
$2,265,730Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2024 · AI
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)
$2,265,730Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AI